Tau protein concentrations in cerebrospinal fluid of non-demented Parkinson's disease patients

Neuroscience Letters

Volumn 238, Issue 3, 1997, Pages 139-141

  Molina, José Antonio ^a   Benito León, Julián ^a   Jiménez Jiménez, Félix Javier ^b   Ortí Pareja, Miguel ^b   Berbel, Angel ^a   Tallón Barranco, Antonio ^a   De Bustos, Fernando ^a   Hernánz, Angel ^c  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^b HOSPITAL UNIVERSITARIO PRÍNCIPE DE ASTURIAS   (Spain)

^c HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

Author keywords

Cerebrospinal fluid; Parkinson's disease; Tau protein

Indexed keywords

BROMOCRIPTINE; LEVODOPA; PERGOLIDE; SELEGILINE; TAU PROTEIN;

ADULT; AGE; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MALE; ONSET AGE; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN CEREBROSPINAL FLUID LEVEL;

AGED; AGED, 80 AND OVER; DEMENTIA; FEMALE; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE; TAU PROTEINS;

EID: 0031555296     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(97)00858-6     Document Type: Article

References (21)

1. American Psychiatric Association, Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), American Psychiatric Press, Washington DC, 1994.
2. Blennow K., Wallin A., Agren H., Spenger C., Siegfried J., VanMechelen E. Tau protein in cerebrospinal fluid: a biochemical marker for axonal degeneration in Alzheimer disease? Mol. Chem. Neuropathol. 26:1995;231-245.
3. Chen J.Y., Stern Y., Sano M., Mayeux R. Cumulative risks of developing extrapyramidal signs, psychosis, or myoclonus in the course of Alzheimer's disease. Arch. Neurol. 48:1991;1141-1143.
4. Delacourte A. Pathological tau proteins of Alzheimer's disease as a biochemical marker of neurofibrillary degeneration. Biomed. Pharmacother. 48:1994;287-295.
5. Fahn, S., Elton R.L. and members of the UPDRS Development Committee, Unified Parkinson's Disease Rating Scale. In S. Fahn, C.D. Marsden, M. Goldstein and D.B. Calne (Eds.), Recent Developments in Parkinson's Disease, Vol. II, MacMillan Helath Care Information, Florham Park, New Jersey, 1987, pp. 153-163.
6. Feany M.B., Dickson D.W. Neurodegenerative disorders with extensive tau pathology: a comparative study and review. Ann. Neurol. 40:1996;139-148.
7. Ghanbari H.A., Miller B.E., Haigler H.J., Arato M., Bissette G., Davies P., Nemeroff C.B., Perry E.K., Perry R., Ravid R., Swaab D.F., Whetsell D., Zemlam F.P. Biochemical assay on Alzheimer's disease-associated protein(s) in human brain tissue. J. Am. Med. Assoc. 263:1990;2907-2910.
8. Harrington C.R., Perry R.H., Perry E.K., Hurt J., McKeith I.G., Roth M., Wischik C.M. Senile dementia of Lewy body type and Alzheimer type are biochemically distinct in terms of paired helicoidal filaments and hyperphosphorylated tau protein. Dementia. 5:1994;215-228.
9. Hock C., Golombowski S., Naser W., Müller-Spahn F. Increase levels of tau protein in cerebrospinal fluid of patients with Alzheimer's disease: correlation with degree of cognitive impairment. Ann. Neurol. 37:1995;414-415.
10. Hoehn M.M., Yahr M.D. Parkinsonism: onset, progression, and mortality. Neurology. 17:1967;419-423.
11. Hughes A.J., Ben-Shlomo S.E., Daniel S.E., Lees A.J. What features improve the accuracy of clinical diagnosis in Parkinson's disease. A clinicopathological study. Neurology. 42:1992;1142-1146.
12. Mayeux R., Denaro J., Hemenegildo N., Marder K., Tang M.X., Côté L.J., Stern Y. A population-based investigation of Parkinson's disease with and without dementia: relationship to age and gender. Arch. Neurol. 49:1992;492-497.
13. Moreu, E., Molinero, L.M. and Fernández, E., R-Sigma: Base de Datos Bioestadística Para un Ordenador Personal, Horus Hardware, Madrid, 1990.
14. Perry R.H., Irving D., Blessed G., Fairbairn A., Perry E.K. Senile dementia of Lewy type. J. Neurol. Sci. 95:1990;119-139.
15. Rösler N., Wichart I., Jellinger K. Total tau immunoreactivity in lumbar cerebrospinal fluid in patients with Alzheimer's disease. J. Neurol. Neurosurg. Psychiatry. 60:1996;237-238.
16. Strong C., Anderton B.H., Perry R.H., Perry E.K., Ince P.G., Lovenstone S. Abnormally phosphorylated tau protein in senile dementia of Lewy body type and Alzheimer's disease: evidence that the disorders are distinct. Alzheimer Dis. Assoc. Disord. 9:1995;218-222.
17. Tato R.E., Frank A., Hernanz A. Tau protein concentrations in cerebrospinal fluid in patients with dementia of Alzheimer type. J. Neurol. Neurosurg. Psychiatry. 59:1995;280-283.
18. Trojanowski J.Q., Lee V.M.Y. Phosphorylation of normal cytoskeletal proteins in Alzheimer's disease and Lewy body dementias. Ann. N. Y. Acad. Sci. 747:1994;92-109.
19. Trojanowski J.Q., Schmidt M.L., Shin R.W., Bramblett G.T., Rao D., Lee V.M.Y. Altered tau and neurofilament proteins in neurodegenerative disease: diagnostic implications for Alzheimer's disease and Lewy body dementias. Brain. Pathol. 3:1993;45-54.
20. Vermesch P., Delacourte A., Javoy-Agid F. Hauw, J.J. and Agid, Y, Dementia in Parkinson's disease: biochemical evidence for cortical involvement using the immunodetection of abnormal proteins. Ann. Neurol. 33:1993;445-450.
21. Vigo-Pelfrey C., Seubert P., Barbour R., Blomquist C., Lee M., Lee D., Coria F., Chang L., Miller B., Lieberburg I., Schenk D. Elevation of microtubule-associated protein tau in the cerebrospinal fluid of patients with Alzheimer's disease. Neurology. 45:1995;788-793.